2m 2m 2m 2m 2m 2m 2m
TARSUS PHARMA (TARS)
NASDAQ
$73.09-$2.37 (-3.15%)
Price as of Oct 02, 2026 4:19 PM EDT- $3.5BMarket Cap
- 28.40%1-Year Change
- BiotechnologyIndustry
TARSUS PHARMA (TARS)
$73.09-$2.37 (-3.15%)
TARS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $75.46 | ||
Change | -$3.15 (-4.01%) | ||
Open | $78.45 | ||
High | $79.10 | ||
Low | $75.03 | ||
Previous Close | $78.61 | ||
Volume | 1,242,147 | ||
30-Day Average Volume | 854,019 | ||
1-Week Change | -0.66% | ||
1-Month Change | 1.90% | ||
1-Year Change | 28.40% | ||
3-Year Change | 324.65% | ||
5-Year Change | 248.22% | ||
Fundamentals | |||
Shares Outstanding | 46.8M | ||
Total Assets | $611.1M | ||
Market Cap | $3.5B | ||
Enterprise Value | $3.4B | ||
Period: QTR TTM FY | |||
Revenue | $173.9M | ||
Net Income | -$18.6M | ||
Free Cash Flow | $57.2M | ||
EBIT | -$13.7M | ||
EBITDA | -$13.4M | ||
Net Working Capital | $386.2M | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -253 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 10 | ||
P/E | -175 | ||
PEG | 1 | ||
Price/Free Cash Flow | 62 | ||
Price/Operating Cash Flow | 58 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue